M Crumbaker

Medical oncologist specialised in genito-urinary malignancies

[Louise Emmett @drlouiseemmett]

First patients injected with Ac225-PSMA-617 on the phase I AcTION trial at @SVHSydney today. Great to be joining @SathegkeM at #Steve Biko Hospital in this trial. Thanks to #Alfred Morgenstern, @AnthonyMJoshua @mcrumbaker1 and our amazing radiochemists, MRS and trials team.

[Louise Emmett @drlouiseemmett]

Great work team. First prospective combination LuPSMA trial demonstrating safety and efficacy in end stage mCRPC. @AnthonyMJoshua @SVHSydney @noxopharm @adacap_news @GarvanInstitute @sarennya

[Louise Emmett @drlouiseemmett]

Great to see #ENZAp open at @SVHSydney and @Austin_Health!
An Australian randomised combination Lu PSMA trial pre chemo in mCRPC. Thanks to @ANZUPtrials @TrialsCentre #ARTnet #ProstateCancerResearchAlliance @MovemberAUS @ANSTO @adacap_news @AstellasUS